TriSalus Life Sciences (TLSI)

Profile

Full Name

TriSalus Life Sciences, Inc.

Ticker Symbol

TLSI

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 8, 2021

Indexes

Not included

Website

http://trisaluslifesci.com

Employees

116

Key Details

Price

$5.73(+3.80%)

Market cap

$179.23M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$29.43M(+58.99% YoY)

Annual EPS

-$1.31(+80.53% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.73
TLSI price is $5.73

30-Day Relative Volume

1.29
TLSI 30-day relative volume is 1.29

Price Performance

Price Most recent change

+3.8%
TLSI price was up +3.8% on Apr 16, 2025

Price YTD change

+14.37%
TLSI price is up +14.37% since January 1st

Price 1-year change

-40.44%
TLSI price is down -40.44% year-on-year

Price 3-year change

-41.71%
TLSI price is down -41.71% over the past 3 years

Price Range

Price All-time high

$12.83
TLSI price is currently -55.34% below its historical high of $12.83

Price 3-year low

$3.32
TLSI price is currently +72.59% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$179.23M
TLSI market capitalization is $179.23 million

Market cap 3-year change

-
TLSI market capitalization 3-year change is unknown

Market cap All-time high

$302.91M
TLSI market capitalization is currently -40.83% below its historical high of $302.91 million

Market cap sector rank

55.84%
TLSI market capitalization is higher than 55.84% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+16.9%
TLSI shares outstanding is up +16.9% year-on-year

Shares Outstanding 3-Year Change

-
TLSI shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.25
TLSI beta is 0.25

200-day SMA

$4.97
TLSI price is currently +15.26% above its 200-day simple moving average

50-day SMA

$5.49
TLSI price is currently +4.39% above its 50-day simple moving average

RSI

59.55
TLSI 14-day relative strength index is 59.55

Volume

1.29
TLSI 30-day relative volume is 1.29

ATR

$0.33
TLSI average true range is $0.33

10-day Historical Volatility

50.72%
TLSI 10-day historical volatility is 50.72%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$29.43M
TLSI annual revenue is $29.43 million

Revenue Analysts estimate

$45.01M
TLSI annual revenue is currently -34.62% lower than the consensus analysts' forecast

Revenue 1-year change

+58.99%
TLSI annual revenue is up +58.99% year-on-year

Revenue Sector rank

38.99%
TLSI annual revenue is higher than 38.99% of companies in Healthcare sector

EPS

EPS

-$1.31
TLSI annual earnings per share is -$1.31

EPS Analysts estimate

-$0.61
TLSI annual earnings per share is currently +113.60% higher than the consensus analysts' forecast

EPS 1-year change

+80.53%
TLSI annual earnings per share is up +80.53% year-on-year

EPS Sector rank

49.46%
TLSI annual earnings per share is higher than 49.46% of companies in Healthcare sector

Profit

Gross profit

$25.33M
TLSI annual gross profit is $25.33 million

Gross margin

86.06%
TLSI annual gross profit margin is 86.06%

Operating profit

-$36.16M
TLSI annual operating income is -$36.16 million

Operating margin

-122.88%
TLSI annual operating profit margin is -122.88%

Net income

-$30.05M
TLSI annual net profit is -$30.05 million

Net margin

-102.09%
TLSI annual net profit margin is -102.09%

Expenses

Total expenses

$65.60M
TLSI annual total expenses is $65.60 million

Operating expenses

$61.49M
TLSI annual total operating expenses is $61.49 million

Cost of goods sold

$4.10M
TLSI annual cost of goods sold is $4.10 million

Selling, general & administrative expenses

$43.80M
TLSI annual SGA is $43.80 million

Depreciation and amortization

-
TLSI annual depreciation & amortization value is unknown

Interest expense

$3.09M
TLSI annual interest expense is $3.09 million

Income tax

$6000.00
TLSI annual income tax is $6000.00

EBIT & EBITDA

EBIT

-$26.95M
TLSI annual earnings before interest & taxes is -$26.95 million

EBITDA

-$26.95M
TLSI annual EBITDA is -$26.95 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$23.97M
TLSI annual total assets is $23.97 million

Non current assets

$3.30M
TLSI annual long term assets is $3.30 million

Current assets

$20.67M
TLSI annual total current assets is $20.67 million

Cash and cash equivalents

$8.53M
TLSI annual cash & cash equivalents is $8.53 million

Accounts receivable

$5.09M
TLSI annual accounts receivable is $5.09 million

Inventory

$4.05M
TLSI annual inventory is $4.05 million

Liabilities

Total liabilities

$49.87M
TLSI annual total liabilities is $49.87 million

Long term liabilities

$39.64M
TLSI annual total long term liabilities is $39.64 million

Current liabilities

$10.23M
TLSI annual total current liabilities is $10.23 million

Accounts payable

$2.27M
TLSI annual accounts payable is $2.27 million

Debt

Total debt

$23.63M
TLSI annual total debt is $23.63 million

Total debt 1-year change

+1381.44%
TLSI annual total debt is up +1381.44% year-on-year

Long term debt

$23.41M
TLSI annual long term debt is $23.41 million

Short term debt

$216.00K
TLSI annual short term debt is $216.00 thousand

Equity & Capital

Shareholders equity

-$25.89M
TLSI annual stockholders equity is -$25.89 million

Book value

-$25.89M
TLSI annual book value is -$25.89 million

Retained earnings

-$279.55M
TLSI annual retained earnings is -$279.55 million

Working capital

$10.44M
TLSI annual working capital is $10.44 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-
TLSI annual cash flow from operations value is unknown

Cash from operations 1-year change

-
TLSI annual cash flow from operations 1-year change is unknown

Cash from investing

-
TLSI annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
TLSI annual cash flow from investing activities 1-year change is unknown

Cash from financing

-
TLSI annual cash flow from financing activities value is unknown

Cash from financing 1-year change

-
TLSI annual cash flow from financing activities 1-year change is unknown

CAPEX

CAPEX

-
TLSI annual capital expenditures value is unknown

CAPEX 1-year change

-
TLSI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-
TLSI annual free cash flow value is unknown

Free cash flow 1-year change

-
TLSI annual free cash flow 1-year change is unknown

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

86.06%
TLSI annual gross profit margin is 86.06%

Operating margin

-122.88%
TLSI annual operating profit margin is -122.88%

Net margin

-102.09%
TLSI annual net profit margin is -102.09%

ROA & ROE

ROA

-120.92%
TLSI annual return on assets is -120.92%

ROE

116.03%
TLSI annual return on equity is 116.03%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TLSI price to earnings ratio value is unknown

PE ratio Sector rank

-
TLSI price to earnings ratio is unknown

PB Ratio

PB ratio

-6.92
TLSI price to book ratio is -6.92

PB ratio Sector rank

3.05%
TLSI price to book ratio is higher than 3.05% of companies in Healthcare sector

PS Ratio

PS ratio

6.09
TLSI price to sales ratio is 6.09

PS ratio Sector rank

70.51%
TLSI price to sales ratio is higher than 70.51% of companies in Healthcare sector

Enterprise value

Enterprise value

$194.33M
TLSI enterprise value is $194.33 million

Enterprise value Sector rank

59.14%
TLSI enterprise value is higher than 59.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.36
TLSI EV/EBITDA is -7.36

EV/EBITDA Sector rank

14.53%
TLSI EV/EBITDA is higher than 14.53% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.02
TLSI annual current ratio is 2.02

Quick ratio

1.63
TLSI annual quick ratio is 1.63

Leverage

Debt to equity

-0.85
TLSI annual debt to equity ratio is -0.85

Interest coverage ratio

-8.72
TLSI annual interest coverage ratio is -8.72

Risk & Stability

Piotroski F-Score

-
TLSI piotroski f-score value is unknown

Altman Z-Score

-16.13
TLSI altman z-score is -16.13

Analyst ratings

Recent major analysts updates

Mar 28, 25 Canaccord Genuity
Buy
Feb 13, 25 Lake Street
Buy
Jan 24, 25 Roth MKM
Buy
Dec 17, 24 Cantor Fitzgerald
Overweight
Nov 15, 24 Canaccord Genuity
Buy
Nov 11, 24 Roth MKM
Buy
Oct 25, 24 Northland Capital Markets
Outperform
Sep 16, 24 Oppenheimer
Outperform
Jun 27, 24 Canaccord Genuity
Buy
May 30, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

TuHURA Biosciences (HURA)
ELDN logo
Eledon Pharmaceuticals (ELDN)
DRTS logo
Alpha Tau Medical (DRTS)
HITI logo
High Tide (HITI)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
INGN logo
Inogen (INGN)
CDXS logo
Codexis (CDXS)
GNFT logo
Genfit SA (GNFT)
MDWD logo
MediWound (MDWD)
  • What is the ticker symbol for TriSalus Life Sciences?
  • Does TriSalus Life Sciences pay dividends?
  • What sector is TriSalus Life Sciences in?
  • What industry is TriSalus Life Sciences in?
  • What country is TriSalus Life Sciences based in?
  • When did TriSalus Life Sciences go public?
  • Is TriSalus Life Sciences in the S&P 500?
  • Is TriSalus Life Sciences in the NASDAQ 100?
  • Is TriSalus Life Sciences in the Dow Jones?
  • When was TriSalus Life Sciences's last earnings report?
  • When does TriSalus Life Sciences report earnings?
  • Should I buy TriSalus Life Sciences stock now?

What is the ticker symbol for TriSalus Life Sciences?

The ticker symbol for TriSalus Life Sciences is NASDAQ:TLSI

Does TriSalus Life Sciences pay dividends?

No, TriSalus Life Sciences does not pay dividends

What sector is TriSalus Life Sciences in?

TriSalus Life Sciences is in the Healthcare sector

What industry is TriSalus Life Sciences in?

TriSalus Life Sciences is in the Medical Devices industry

What country is TriSalus Life Sciences based in?

TriSalus Life Sciences is headquartered in United States

When did TriSalus Life Sciences go public?

TriSalus Life Sciences's initial public offering (IPO) was on February 8, 2021

Is TriSalus Life Sciences in the S&P 500?

No, TriSalus Life Sciences is not included in the S&P 500 index

Is TriSalus Life Sciences in the NASDAQ 100?

No, TriSalus Life Sciences is not included in the NASDAQ 100 index

Is TriSalus Life Sciences in the Dow Jones?

No, TriSalus Life Sciences is not included in the Dow Jones index

When was TriSalus Life Sciences's last earnings report?

TriSalus Life Sciences's most recent earnings report was on Mar 27, 2025

When does TriSalus Life Sciences report earnings?

The next expected earnings date for TriSalus Life Sciences is May 15, 2025

Should I buy TriSalus Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page